Inhibition of the SET/MLL Histone Methyltransferase Complex as a Novel Epigenetic Targeted Therapy in Mixed Lineage Leukemia

MLA

Robert Bostwick, et al. “Inhibition of the SET/MLL Histone Methyltransferase Complex as a Novel Epigenetic Targeted Therapy in Mixed Lineage Leukemia.” The FASEB Journal, vol. 35, May 2021. EBSCOhost, https://doi.org/10.1096/fasebj.2021.35.s1.01759.

APA

Robert Bostwick, Corinne Augello-Szafran, William J. Placzek, Hayley Widden, Anish Vadukoot, Rebecca J. Boohaker, Mark J. Suto, Omar Moukha-Chafiq, & Robert H. Whitaker. (2021). Inhibition of the SET/MLL Histone Methyltransferase Complex as a Novel Epigenetic Targeted Therapy in Mixed Lineage Leukemia. The FASEB Journal, 35. https://doi.org/10.1096/fasebj.2021.35.s1.01759

Chicago

Robert Bostwick, Corinne Augello-Szafran, William J. Placzek, Hayley Widden, Anish Vadukoot, Rebecca J. Boohaker, Mark J. Suto, Omar Moukha-Chafiq, and Robert H. Whitaker. 2021. “Inhibition of the SET/MLL Histone Methyltransferase Complex as a Novel Epigenetic Targeted Therapy in Mixed Lineage Leukemia.” The FASEB Journal 35 (May). doi:10.1096/fasebj.2021.35.s1.01759.